In this work, we demonstrated that siRNA-mediated USP22 depletion as well as using the USP22-specific small molecule inhibitor USP22i-S02 [32] impairs the OXPHOS-transcriptomic program and abrogates the basal respiratory capacity of HER2+-BC and TNBC cells. The gene discussed is ERBB2; the disease is breast cancer.